R&D JP Morgan Week 2025 – Steve Pakola On the sidelines of JP Morgan in San Francisco, editor-in-chief Jonah Comstock caught up with Steven Pakola, REGENXBIO’s chief medical officer.
R&D Sponsored Exploring the future: Opportunities and challenges in cell a... Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
R&D Life Sciences Industry Report - Rare Disease Space There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.
R&D Pharma holds it breath for ’25 as the sun shines on JP Morga... The JP Morgan Healthcare Conference is seen as a barometer for the life sciences industry – and, going into this year’s event, the forecast for the year was particularly grim.
R&D Six life sciences real estate trends to watch in 2025 Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs.
R&D JP Morgan Week 2025 - Fabrizio Chines In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.
News Zuckerberg, Chan's Biohub launches protein 'world model' Chan Zuckberg Initiative-backed Biohub has made what it says is an AI-powered "world model" of protein biology available freely to researchers.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
